SlideShare una empresa de Scribd logo
1 de 8
HIV1- identification of the specific restriction factor SAMHD1 Monsef Benkirane Institut de Génétique Humaine Montpellier CEA CHRU CNRS CPU INRA INRIA INSERM INSTITUT PASTEUR IRD
Dendritic cells are refractory to HIV-1 infection Does HIV-1 escapes innate immune recognition by avoiding productive infection of Dendritic cells? X
>  Initially isolated as an IFN  -induced factor in macrophages  and dendritic cells > Like for  TREX1  and  RNASEH2,  mutations in  SAMHD1  results in Aicardi Goutière Syndrome AGS AGS is a rare genetic disorder  that mimics symptoms from  a congenital infection   AGS is associated with an increased production of IFN α Purification of Vpx-associated proteins SAM domain and HD domain 1 Protein-Protein interaction domain SAM HD Putative hydrolase domain 45 110 164 319 626 1 Missing in isoform 2  113-126
Vpx interacts and induces proteasomal degradation of SAMHD1 SAMHD1 expression correlates with HIV-1 susceptibility F/H-Vpx: SAMHD1 Tubulin + F/H-Vpx WCE DDB1 - R.S.I. 1 0.05 0.7 SAMHD1 Tubulin DDB1 Mg132: - + - VLP-Vpx: + + - shRNA Scr (4) Fold increase  Vpx/no Vpx N.I. HIV-LUC-G shRNA Scr (3) (4) Fold Increase x12 x4 Silencing N.I. HIV-LUC-G
SAMHD1 restricts HIV-1 infection of Dendritic cells Silencing of SAMHD1  in MDDCs Infection of silenced MDDCs with LV-GFP Infection of silenced MDDCs with HIV-G Dynamin-2 siRNA: - Scr Dyn2 Actin 16 4 0.4 62 22 0.1 65 26 0.2 21 4 0.1 GFP FSC Scr Dyn2 SAMHD1-1 SAMHD1-2 siRNA: N.I. LV GFP 5ng LV GFP  50ng 1 2 48 hr 96 hr SAMHD1 DDB1 Tubulin siRNA: - Scr 1 2 Scr 1 2 HD2 siRNA Fold increase  (p24+ cells) Scr 1 2 HD4 0 10 20 30 40
The big picture Would decreasing Samhd1 levels allow for better immune control of HIV-1 infection?
Conclusion and perspectives SAMHD1 is the dendritic and myeloid cells-specific HIV-1-restriction factor counteracted by Vpx ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Many thanks to: LAGUETTE Nadine CHABLE-BESSIA Christine  SOBHIAN Bijan  RINGEARD Mathieu  YATIM Ahmad  SCHWARTZ Olivier CASARTELLI Nicoletta EMILIANI Stéphane SEGERAL Emmanuel

Más contenido relacionado

La actualidad más candente

Presentation Sirion Web V7 Spoken
Presentation Sirion Web V7 SpokenPresentation Sirion Web V7 Spoken
Presentation Sirion Web V7 Spokenbiofrost
 
Current approaches for African swine fever virus vaccine development
Current approaches for African swine fever virus vaccine developmentCurrent approaches for African swine fever virus vaccine development
Current approaches for African swine fever virus vaccine developmentILRI
 
Unraveling the Rpg1-mediated Stem Rust Resistance in Barley
Unraveling the Rpg1-mediated Stem Rust Resistance in BarleyUnraveling the Rpg1-mediated Stem Rust Resistance in Barley
Unraveling the Rpg1-mediated Stem Rust Resistance in BarleyBorlaug Global Rust Initiative
 
Antibody mediated in vivo delivery of siRNA via cell surface receptors
Antibody mediated in vivo delivery of siRNA via cell surface receptorsAntibody mediated in vivo delivery of siRNA via cell surface receptors
Antibody mediated in vivo delivery of siRNA via cell surface receptorsEsakki Muthu Lakshmi Venkatesh
 
Extended Letermovir Prophylactic Therapy as CMV Prophylaxis in Graft-versus-H...
Extended Letermovir Prophylactic Therapy as CMV Prophylaxis in Graft-versus-H...Extended Letermovir Prophylactic Therapy as CMV Prophylaxis in Graft-versus-H...
Extended Letermovir Prophylactic Therapy as CMV Prophylaxis in Graft-versus-H...Vijay Elipay
 

La actualidad más candente (8)

Presentation Sirion Web V7 Spoken
Presentation Sirion Web V7 SpokenPresentation Sirion Web V7 Spoken
Presentation Sirion Web V7 Spoken
 
Current approaches for African swine fever virus vaccine development
Current approaches for African swine fever virus vaccine developmentCurrent approaches for African swine fever virus vaccine development
Current approaches for African swine fever virus vaccine development
 
Antiretroviral
AntiretroviralAntiretroviral
Antiretroviral
 
Hiv life cycle
Hiv life cycleHiv life cycle
Hiv life cycle
 
Unraveling the Rpg1-mediated Stem Rust Resistance in Barley
Unraveling the Rpg1-mediated Stem Rust Resistance in BarleyUnraveling the Rpg1-mediated Stem Rust Resistance in Barley
Unraveling the Rpg1-mediated Stem Rust Resistance in Barley
 
Chemotherapy of hiv
Chemotherapy of hivChemotherapy of hiv
Chemotherapy of hiv
 
Antibody mediated in vivo delivery of siRNA via cell surface receptors
Antibody mediated in vivo delivery of siRNA via cell surface receptorsAntibody mediated in vivo delivery of siRNA via cell surface receptors
Antibody mediated in vivo delivery of siRNA via cell surface receptors
 
Extended Letermovir Prophylactic Therapy as CMV Prophylaxis in Graft-versus-H...
Extended Letermovir Prophylactic Therapy as CMV Prophylaxis in Graft-versus-H...Extended Letermovir Prophylactic Therapy as CMV Prophylaxis in Graft-versus-H...
Extended Letermovir Prophylactic Therapy as CMV Prophylaxis in Graft-versus-H...
 

Similar a 2.2 monsef benkirane

Pharmacology and therapeutics of Antiretroviral agent
Pharmacology and therapeutics of Antiretroviral agentPharmacology and therapeutics of Antiretroviral agent
Pharmacology and therapeutics of Antiretroviral agentPrajwalGhatol1
 
6 immunology-csbrp
6 immunology-csbrp6 immunology-csbrp
6 immunology-csbrpPrasad CSBR
 
Atherosclerosis: New Insights on Foamy Macrophage Induction and Persistence
Atherosclerosis: New Insights on Foamy Macrophage Induction and PersistenceAtherosclerosis: New Insights on Foamy Macrophage Induction and Persistence
Atherosclerosis: New Insights on Foamy Macrophage Induction and PersistenceDr. Marian Laderoute
 
Immuno presentation: hiv
Immuno presentation: hivImmuno presentation: hiv
Immuno presentation: hivAindrila Saha
 
B. Charleston - The application of new vaccine technologies to control high c...
B. Charleston - The application of new vaccine technologies to control high c...B. Charleston - The application of new vaccine technologies to control high c...
B. Charleston - The application of new vaccine technologies to control high c...EuFMD
 
Systemic lupus erythematosis & Kawasaki disease
Systemic lupus erythematosis & Kawasaki diseaseSystemic lupus erythematosis & Kawasaki disease
Systemic lupus erythematosis & Kawasaki diseaseTai Alakawy
 
Sigmaxi mrn ga mrn
Sigmaxi mrn ga mrnSigmaxi mrn ga mrn
Sigmaxi mrn ga mrngcantell
 
Sigma Xi Presentation
Sigma Xi PresentationSigma Xi Presentation
Sigma Xi Presentationgcantell
 

Similar a 2.2 monsef benkirane (20)

Antiviral drugs
Antiviral drugsAntiviral drugs
Antiviral drugs
 
Anti viral 1
Anti viral 1Anti viral 1
Anti viral 1
 
COVID-19 January 2022.pptx
COVID-19 January 2022.pptxCOVID-19 January 2022.pptx
COVID-19 January 2022.pptx
 
COVID-19 January 2022.pptx
COVID-19 January 2022.pptxCOVID-19 January 2022.pptx
COVID-19 January 2022.pptx
 
Cd20 antibody
Cd20 antibodyCd20 antibody
Cd20 antibody
 
Antivirals
AntiviralsAntivirals
Antivirals
 
Pharmacology and therapeutics of Antiretroviral agent
Pharmacology and therapeutics of Antiretroviral agentPharmacology and therapeutics of Antiretroviral agent
Pharmacology and therapeutics of Antiretroviral agent
 
Diagnóstico funcional y genético de las inmunodeficiencias primarias
Diagnóstico funcional y genético de las inmunodeficiencias primariasDiagnóstico funcional y genético de las inmunodeficiencias primarias
Diagnóstico funcional y genético de las inmunodeficiencias primarias
 
6 immunology-csbrp
6 immunology-csbrp6 immunology-csbrp
6 immunology-csbrp
 
Atherosclerosis: New Insights on Foamy Macrophage Induction and Persistence
Atherosclerosis: New Insights on Foamy Macrophage Induction and PersistenceAtherosclerosis: New Insights on Foamy Macrophage Induction and Persistence
Atherosclerosis: New Insights on Foamy Macrophage Induction and Persistence
 
Anti viral drugs
Anti viral drugsAnti viral drugs
Anti viral drugs
 
Antiviral agents
Antiviral agentsAntiviral agents
Antiviral agents
 
Scientific Sessions 2015: HIV and genetics
Scientific Sessions 2015: HIV and geneticsScientific Sessions 2015: HIV and genetics
Scientific Sessions 2015: HIV and genetics
 
Immuno presentation: hiv
Immuno presentation: hivImmuno presentation: hiv
Immuno presentation: hiv
 
B. Charleston - The application of new vaccine technologies to control high c...
B. Charleston - The application of new vaccine technologies to control high c...B. Charleston - The application of new vaccine technologies to control high c...
B. Charleston - The application of new vaccine technologies to control high c...
 
The Latest on HIV Cure Strategies
The Latest on HIV Cure StrategiesThe Latest on HIV Cure Strategies
The Latest on HIV Cure Strategies
 
Systemic lupus erythematosis & Kawasaki disease
Systemic lupus erythematosis & Kawasaki diseaseSystemic lupus erythematosis & Kawasaki disease
Systemic lupus erythematosis & Kawasaki disease
 
Sigmaxi mrn ga mrn
Sigmaxi mrn ga mrnSigmaxi mrn ga mrn
Sigmaxi mrn ga mrn
 
Sigma Xi Presentation
Sigma Xi PresentationSigma Xi Presentation
Sigma Xi Presentation
 
5.4 Caerina
5.4 Caerina5.4 Caerina
5.4 Caerina
 

Más de Association LIR

The relationship between_health_and_growth
The relationship between_health_and_growthThe relationship between_health_and_growth
The relationship between_health_and_growthAssociation LIR
 
Policies for conflicts_of_interest_lir_2011
Policies for conflicts_of_interest_lir_2011Policies for conflicts_of_interest_lir_2011
Policies for conflicts_of_interest_lir_2011Association LIR
 
Observatoire bipe presentation_presse
Observatoire bipe presentation_presseObservatoire bipe presentation_presse
Observatoire bipe presentation_presseAssociation LIR
 
Impact sur la_longevite_et_croissance_economique
Impact sur la_longevite_et_croissance_economiqueImpact sur la_longevite_et_croissance_economique
Impact sur la_longevite_et_croissance_economiqueAssociation LIR
 
Etude enjeux-vieillissement
Etude enjeux-vieillissementEtude enjeux-vieillissement
Etude enjeux-vieillissementAssociation LIR
 
Enquete attractivite-lir leem-aec
Enquete attractivite-lir leem-aecEnquete attractivite-lir leem-aec
Enquete attractivite-lir leem-aecAssociation LIR
 
Consommation de medicaments_dans_5_pays_europeens
Consommation de medicaments_dans_5_pays_europeensConsommation de medicaments_dans_5_pays_europeens
Consommation de medicaments_dans_5_pays_europeensAssociation LIR
 
Prise en-charge-personnes-agees
Prise en-charge-personnes-ageesPrise en-charge-personnes-agees
Prise en-charge-personnes-ageesAssociation LIR
 
Linnovation en sante_lespoir_des_francais
Linnovation en sante_lespoir_des_francaisLinnovation en sante_lespoir_des_francais
Linnovation en sante_lespoir_des_francaisAssociation LIR
 
Dp debats femmes-et_sante
Dp debats femmes-et_santeDp debats femmes-et_sante
Dp debats femmes-et_santeAssociation LIR
 
Publication ph-aghion-croissance-et-sante
Publication ph-aghion-croissance-et-santePublication ph-aghion-croissance-et-sante
Publication ph-aghion-croissance-et-santeAssociation LIR
 
Proposition+alliance+sur+info+patien+gp +assmed-avril2011
Proposition+alliance+sur+info+patien+gp +assmed-avril2011Proposition+alliance+sur+info+patien+gp +assmed-avril2011
Proposition+alliance+sur+info+patien+gp +assmed-avril2011Association LIR
 
Policies for conflicts_of_interest
Policies for conflicts_of_interestPolicies for conflicts_of_interest
Policies for conflicts_of_interestAssociation LIR
 
Lir2011 discours vpecresse-
Lir2011 discours vpecresse-Lir2011 discours vpecresse-
Lir2011 discours vpecresse-Association LIR
 
Lir+ resultats+observatoire+septembre+2012
Lir+ resultats+observatoire+septembre+2012Lir+ resultats+observatoire+septembre+2012
Lir+ resultats+observatoire+septembre+2012Association LIR
 

Más de Association LIR (20)

The relationship between_health_and_growth
The relationship between_health_and_growthThe relationship between_health_and_growth
The relationship between_health_and_growth
 
Policies for conflicts_of_interest_lir_2011
Policies for conflicts_of_interest_lir_2011Policies for conflicts_of_interest_lir_2011
Policies for conflicts_of_interest_lir_2011
 
Observatoire bipe presentation_presse
Observatoire bipe presentation_presseObservatoire bipe presentation_presse
Observatoire bipe presentation_presse
 
Impact sur la_longevite_et_croissance_economique
Impact sur la_longevite_et_croissance_economiqueImpact sur la_longevite_et_croissance_economique
Impact sur la_longevite_et_croissance_economique
 
Etude enjeux-vieillissement
Etude enjeux-vieillissementEtude enjeux-vieillissement
Etude enjeux-vieillissement
 
Enquete attractivite-lir leem-aec
Enquete attractivite-lir leem-aecEnquete attractivite-lir leem-aec
Enquete attractivite-lir leem-aec
 
Consommation de medicaments_dans_5_pays_europeens
Consommation de medicaments_dans_5_pays_europeensConsommation de medicaments_dans_5_pays_europeens
Consommation de medicaments_dans_5_pays_europeens
 
Prise en-charge-personnes-agees
Prise en-charge-personnes-ageesPrise en-charge-personnes-agees
Prise en-charge-personnes-agees
 
Linnovation en sante_lespoir_des_francais
Linnovation en sante_lespoir_des_francaisLinnovation en sante_lespoir_des_francais
Linnovation en sante_lespoir_des_francais
 
Dp debats femmes-et_sante
Dp debats femmes-et_santeDp debats femmes-et_sante
Dp debats femmes-et_sante
 
Mesure prioritaire 4
Mesure prioritaire 4Mesure prioritaire 4
Mesure prioritaire 4
 
Mesure prioritaire 2
Mesure prioritaire 2Mesure prioritaire 2
Mesure prioritaire 2
 
Mesure prioritaire 1
Mesure prioritaire 1Mesure prioritaire 1
Mesure prioritaire 1
 
Mesure prioritaire 3
Mesure prioritaire 3Mesure prioritaire 3
Mesure prioritaire 3
 
Publication ph-aghion-croissance-et-sante
Publication ph-aghion-croissance-et-santePublication ph-aghion-croissance-et-sante
Publication ph-aghion-croissance-et-sante
 
Proposition+alliance+sur+info+patien+gp +assmed-avril2011
Proposition+alliance+sur+info+patien+gp +assmed-avril2011Proposition+alliance+sur+info+patien+gp +assmed-avril2011
Proposition+alliance+sur+info+patien+gp +assmed-avril2011
 
Policies for conflicts_of_interest
Policies for conflicts_of_interestPolicies for conflicts_of_interest
Policies for conflicts_of_interest
 
Lir2011 discours vpecresse-
Lir2011 discours vpecresse-Lir2011 discours vpecresse-
Lir2011 discours vpecresse-
 
Lir+ resultats+observatoire+septembre+2012
Lir+ resultats+observatoire+septembre+2012Lir+ resultats+observatoire+septembre+2012
Lir+ resultats+observatoire+septembre+2012
 
Lir plateforme-2010
Lir plateforme-2010Lir plateforme-2010
Lir plateforme-2010
 

Último

ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATROKanhu Charan
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUELMKARTHIKEMMANUEL
 
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...marcuskenyatta275
 
Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examJunhao Koh
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)Monika Kanwar
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale nowSherrylee83
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartMedicoseAcademics
 
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...ocean4396
 
5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor rawSherrylee83
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationMedicoseAcademics
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadNephroTube - Dr.Gawad
 
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?DrShinyKajal
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenRaju678948
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxSamar Tharwat
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionGolden Helix
 
Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifierNidhi Joshi
 
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON  .pptxDIGITAL RADIOGRAPHY-SABBU KHATOON  .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptxSabbu Khatoon
 
Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Anjali Parmar
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...Ayman Seddik
 

Último (20)

ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
 
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. MacklinScleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
 
Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES exam
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
 
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
 
5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in children
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifier
 
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON  .pptxDIGITAL RADIOGRAPHY-SABBU KHATOON  .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
 
Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 

2.2 monsef benkirane

  • 1. HIV1- identification of the specific restriction factor SAMHD1 Monsef Benkirane Institut de Génétique Humaine Montpellier CEA CHRU CNRS CPU INRA INRIA INSERM INSTITUT PASTEUR IRD
  • 2. Dendritic cells are refractory to HIV-1 infection Does HIV-1 escapes innate immune recognition by avoiding productive infection of Dendritic cells? X
  • 3. > Initially isolated as an IFN  -induced factor in macrophages and dendritic cells > Like for TREX1 and RNASEH2, mutations in SAMHD1 results in Aicardi Goutière Syndrome AGS AGS is a rare genetic disorder that mimics symptoms from a congenital infection AGS is associated with an increased production of IFN α Purification of Vpx-associated proteins SAM domain and HD domain 1 Protein-Protein interaction domain SAM HD Putative hydrolase domain 45 110 164 319 626 1 Missing in isoform 2 113-126
  • 4. Vpx interacts and induces proteasomal degradation of SAMHD1 SAMHD1 expression correlates with HIV-1 susceptibility F/H-Vpx: SAMHD1 Tubulin + F/H-Vpx WCE DDB1 - R.S.I. 1 0.05 0.7 SAMHD1 Tubulin DDB1 Mg132: - + - VLP-Vpx: + + - shRNA Scr (4) Fold increase Vpx/no Vpx N.I. HIV-LUC-G shRNA Scr (3) (4) Fold Increase x12 x4 Silencing N.I. HIV-LUC-G
  • 5. SAMHD1 restricts HIV-1 infection of Dendritic cells Silencing of SAMHD1 in MDDCs Infection of silenced MDDCs with LV-GFP Infection of silenced MDDCs with HIV-G Dynamin-2 siRNA: - Scr Dyn2 Actin 16 4 0.4 62 22 0.1 65 26 0.2 21 4 0.1 GFP FSC Scr Dyn2 SAMHD1-1 SAMHD1-2 siRNA: N.I. LV GFP 5ng LV GFP 50ng 1 2 48 hr 96 hr SAMHD1 DDB1 Tubulin siRNA: - Scr 1 2 Scr 1 2 HD2 siRNA Fold increase (p24+ cells) Scr 1 2 HD4 0 10 20 30 40
  • 6. The big picture Would decreasing Samhd1 levels allow for better immune control of HIV-1 infection?
  • 7.
  • 8. Many thanks to: LAGUETTE Nadine CHABLE-BESSIA Christine SOBHIAN Bijan RINGEARD Mathieu YATIM Ahmad SCHWARTZ Olivier CASARTELLI Nicoletta EMILIANI Stéphane SEGERAL Emmanuel